UBS：2026年全球医疗科技行业深度研究报告（英文版）

Just over a year ago we published a >100 page report which detailed our hypothesis (6- stage framework for Chinese disruption) that Chinese players are uniquely positioned to disrupt previously stable global Medtech markets, leading to lower growth for a number of companies within our coverage. Here we revisit our hypothesis with clear evidence, in our view, that it is playing out. Specifically we reassess the disruptive progress within imaging, diagnostics, orthopaedics, ophthalmology, d